Ozempic maker Novo Nordisk is cutting 9,000 jobs

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth ... Read More

Ozempic maker Novo Nordisk plans cut 9,000 jobs. NC expansion expected to proceed, company says

Novo Nordisk, the Danish drugmaker with a large presence in North Carolina, declined to say how many jobs might be cut in the state. But it indicated a planned Triangle expansion might not be affected ... Read More

Novo to Cut Employee Bonuses in Denmark Due to Slower Growth

Novo Nordisk A/S’s slower growth will crimp employee bonuses in the Ozempic maker’s home market of Denmark as it ramps up a cost-cutting push. The 2025 yearly bonus will be reduced for employees ... Read More

Ozempic Maker Novo Nordisk Is a Problem as Denmark’s Economy Hits a Wall

Denmark cut its annual growth outlook on Friday—and one of the Scandinavian country’s best-known companies may be a part of the problem. The economy ministry said in a press release that it was ... Read More

Novo Nordisk to cut staff bonuses in its home country amid growth concerns

Novo Nordisk (NVO) will be forced to lower employee bonuses in its home country, Denmark, as the company doubles down on a cost-cutting drive following a cut to its growth outlook this year, Bloomberg ... Read More

Novo Nordisk woes prompt Denmark to slash country's 2025 growth forecast

Aug 29 (Reuters) - Denmark has cut its 2025 economic growth forecast to 1.4% from 3%, citing weaker prospects for pharmaceutical giant Novo Nordisk (NOVOb.CO), opens new tab and tariffs on Danish ... Read More

GoodRx, Novo Nordisk partner to offer Ozempic, Wegovy

Prescription savings platform GoodRx is collaborating with pharma giant Novo Nordisk to make Ozempic and Wegovy pens available to eligible self-paying patients using GoodRx for $499 per month at ... Read More

Ozempic Maker Novo Nordisk to Cut 9,000 Jobs

The job cuts represent around 11% of the Ozempic and Wegovy maker’s 78,400 global staff, with the company aiming to deliver total annual savings of around 8 billion Danish kroner, equivalent to $1.25 ... Read More